Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare Q1 revenue rises 6.5%; GAAP EPS falls to $0.61

Mixed Impact 4 of 5 earnings Written later

Prestige Consumer Healthcare reported fiscal first-quarter 2027 revenue of $265.7 million, up 6.5%, with organic growth of 3.2%. GAAP diluted EPS fell to $0.61 from $0.95, while adjusted diluted EPS rose to $0.98 from $0.95 after excluding acquisition costs and Pillar5 facility remediation costs. The company raised its fiscal 2027 revenue and EPS outlook, which it said reflects only the addition of the Breathe Right and LaCorium acquisitions.

Key points

  • Q1 revenue $265.7 million, up 6.5% from $249.5 million; organic revenue growth 3.2%
  • GAAP net income $29.2 million, or $0.61 per diluted share, versus $47.5 million, or $0.95, a year earlier
  • Adjusted diluted EPS $0.98 versus $0.95; adjustments include $12.8 million of acquisition costs and $7.1 million of Pillar5 remediation costs
  • Fiscal 2027 revenue outlook raised to $1,290 to $1,315 million from $1,100 to $1,121 million; adjusted diluted EPS outlook raised to $4.55 to $4.65 from $4.42 to $4.51

The filing

CompanyPrestige Consumer Healthcare (PBH)
Form8-K, current report
Filed with the SECAug 6, 2026, 6:04 AM ET
Accession number0001295947-26-000040

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.